Back to main Insights page

Breaking the Cycle: Cost-Plus vs. Spread Pricing in Pharmacy Benefits

By


Related Insights

  • Why Employers Need a Prescription Drug Strategy Built for Uncertainty
    Employers are being asked to budget for a category in which neither the timing…
    Read More
  • Beyond the Midterms: Why Pharmacy Reform Must Remain a Priority
    As the 2026 midterm elections approach, healthcare policy remains a significant topic of discussion….
    Read More
  • PBM Reform Signals the Future — But Employers and Brokers Don’t Have to Wait 
    The passage of the Consolidated Appropriations Act (CAA) of 2026 represents one of the…
    Read More